PVH
SCNI

Psagot Value Holdings’s Scinai Immunotherapeutics SCNI Stock Holding History

Psagot Value Holdings’s Portfolio SCNI Stock Details SCNI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-109
Closed -$59K – 447
2019
Q1 		$59K Hold
109
– – ﹤0.01% 345
2018
Q4 		$52K Hold
109
– – ﹤0.01% 348
2018
Q3 		$61K Hold
109
– – ﹤0.01% 284
2018
Q2 		$73K Hold
109
– – ﹤0.01% 264
2018
Q1 		$59K Hold
109
– – ﹤0.01% 273
2017
Q4 		$58K Buy
+109
New +$68.5K ﹤0.01% 245

Other funds holding SCNI

BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

Psagot Value Holdings's SCNI Position: Q2 2019 in Review

Psagot Value Holdings sold out of Scinai Immunotherapeutics (SCNI) in Q2 2019, closing a stake of 109 shares — an estimated $59K sold.

Psagot Value Holdings first reported a position in SCNI in Q4 2017 and held it in 6 quarters. The position peaked at $73K in Q2 2018. 7 funds tracked by Wall St. Rank hold SCNI as of Q2 2019.

  • Psagot Value Holdings reported no remaining Scinai Immunotherapeutics position as of Q2 2019 after selling out during the quarter.
  • Psagot Value Holdings sold 109 Scinai Immunotherapeutics shares in Q2 2019, an estimated $59K.
  • Psagot Value Holdings first reported a position in Scinai Immunotherapeutics in Q4 2017 and held it in 6 quarters.
  • Psagot Value Holdings's Scinai Immunotherapeutics position peaked at $73K in Q2 2018.
  • 7 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q2 2019.

Based on Psagot Value Holdings's 13F filing for Q2 2019, filed 29 Jul 2019.